- Integration of CiNii Books functions for fiscal year 2025 has completed
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- Incorporated Jxiv preprints from JaLC and adding coverage from NDL Search
Rimonabant, a specific antagonist of the cannabinoid CB1-receptor, prevents lipopolysaccharide-induced endotoxemia in awake guinea pigs
-
- Inagaki Eiji
- Department of Emergency and Critical Care Medicine, Nippon Medical School
-
- Nemoto Kayo
- Department of Emergency and Critical Care Medicine, Nippon Medical School The Graduate University of Japan Traditional Medicine and Science
-
- Ninomiya Norifumi
- Department of Emergency and Critical Care Medicine, Nippon Medical School
-
- Ishinokami Saori
- Department of Emergency and Critical Care Medicine, Nippon Medical School
-
- Yokota Hiroyuki
- Department of Emergency and Critical Care Medicine, Nippon Medical School
-
- Kubota Minoru
- Department of Clinical Laboratery, Nippon Medical School
Bibliographic Information
- Published
- 2010
- DOI
-
- 10.3893/jjaam.21.118
- Publisher
- Japanese Association for Acute Medicine
Search this article
Description
2-arachidonoyl glycerol (2-AG), an endogenous cannabinoid, has been drawing much attention as an early stage mediator at the onset of sepsis. In the present study, we investigated weather rimonabant, one of the CB1 antagonists, alleviated the medical conditions during endotoxemia and measured the level of prostaglandin E metabolite (PGEM). A cylindrical electric transmitter was connected to the transducer via a cable embedded beneath the animal's dorsal skin and sutured in place. Signals from the transmitter were detected by a receiver placed directly beneath the cage via telemetry. We monitored arterial pressure via catheter in the carotid artery and administrated drugs via catheter in jugular vein. We separated animals into three groups. The control group received lipopolysaccharide (LPS, 0.3 mg/kg, i.v.) and vehicle i.v. Experimental animals received LPS and rimonabant (1, 3 mg/kg/h) i.v. Ten minutes after the injection of the vehicle or rimonabant, LPS (0.3 mg/kg, i.v.) was administered. The prostaglandin E metabolites (PGEM) levels were measured by EIASA. In the control group, LPS induced intestinal paralysis and the decline in blood pressure peaked 1-3h after administration of LPS. In rimonabant-treated group, rimonabant inhibited LPS-induced intestinal paralysis and hypotension. Levels of PGEM in guinea pig was increased by LPS-administrate, rimonabant inhibits PGEM increase. The results suggest that rimonabant was effective against LPS-induced endotoxemia in guinea pigs.
Journal
-
- Nihon Kyukyu Igakukai Zasshi
-
Nihon Kyukyu Igakukai Zasshi 21 (3), 118-125, 2010
Japanese Association for Acute Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679345958656
-
- NII Article ID
- 10030253971
-
- NII Book ID
- AN10284604
-
- ISSN
- 18833772
- 0915924X
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed
